PATENT CLAIM ANALYSIS

Application Number: 15760170
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "450000"]

Abstract:
Lipid nanoparticles and methods of making and using the same, including pharmaceutical compositions and kits, and the targeted delivery of drugs in various treatment methods. The nanoparticle formulation includes phospholipids, triglycerides, cholesterol, cholesteryl ester, apolipoprotein E3 (ApoE3), and a lipophilic therapeutic agent.

Claim (Index 4):
The lipid nanoparticle according to  claim 1 , wherein the lipid core is formed of the cholesterol ester and triglyceride components, and the triglyceride component is selected from the group consisting of castor oil, coconut oil, and soybean oil.

Metadata:
- Claim Count in Document: 66.0
- Percentile: 90.0
- Lexical Diversity: 1.35897
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10724833', '11648808', '11802197', '11513756', '11802727']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7684417306404332
- 35 USC 102 Novelty (BERT): 0.5196083345203247
- Combined Prediction Score: 0.7435583910284224
- Mean Citation Score: 279.559728
- Max Citation Score: 291.0936
- Similarity Product: 191.0599311600208

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test